These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 8465432

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Detection of inhibitory anti-OKT3 antibodies in renal transplant patients.
    Lamm LU, Mathiasen D, Povlsen JV, Pedersen EB, Birkeland SA, Jørgensen KA.
    Transplant Proc; 1994 Jun; 26(3):1730. PubMed ID: 8030107
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The OKT3 Antibody Response Study: a multicentre study of human anti-mouse antibody (HAMA) production following OKT3 use in solid organ transplantation.
    Kimball JA, Norman DJ, Shield CF, Schroeder TJ, Lisi P, Garovoy M, O'Connell JB, Stuart F, McDiarmid SV, Wall W.
    Transpl Immunol; 1995 Sep; 3(3):212-21. PubMed ID: 8581409
    [Abstract] [Full Text] [Related]

  • 8. Antimouse antibody response after OKT3 administration for steroid resistant rejection.
    Kaiser BA, Palmer JA, Dunn SP, Mochon MA, Bartosh SM, Schulman SL, Polinsky MS, Baluarte HJ.
    Child Nephrol Urol; 1991 Sep; 11(4):190-2. PubMed ID: 1777898
    [Abstract] [Full Text] [Related]

  • 9. Sensitization to OKT3 monoclonal antibody in heart transplantation: correlation with early allograft loss.
    O'Connell JB, Renlund DG, Hammond EH, Wittwer CT, Yowell RL, DeWitt CW, Jones KW, Gay WA, Menlove RL, Bristow MR.
    J Heart Lung Transplant; 1991 Sep; 10(2):217-21; discussion 221-2. PubMed ID: 1903303
    [Abstract] [Full Text] [Related]

  • 10. Consensus statement regarding OKT3-induced cytokine-release syndrome and human antimouse antibodies.
    Norman DJ, Chatenoud L, Cohen D, Goldman M, Shield CF.
    Transplant Proc; 1993 Apr; 25(2 Suppl 1):89-92. PubMed ID: 8465436
    [No Abstract] [Full Text] [Related]

  • 11. The incidence of antibody formation to OKT3 consequent to its use in organ transplantation.
    Carey G, Lisi PJ, Schroeder TJ.
    Transplantation; 1995 Jul 27; 60(2):151-8. PubMed ID: 7624957
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Humoral immune response against OKT3.
    Chatenoud L.
    Transplant Proc; 1993 Apr 27; 25(2 Suppl 1):68-73. PubMed ID: 8465430
    [No Abstract] [Full Text] [Related]

  • 14. Immunologic monitoring of OKT3 induction therapy in cardiac allograft recipients.
    Toyoda M, Galfayan K, Wachs K, Czer L, Jordan SC.
    Clin Transplant; 1995 Dec 27; 9(6):472-80. PubMed ID: 8645891
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Clinical role of immunologic monitoring during OKT3 treatment.
    Bhat G, Schroeder TJ.
    Transplant Proc; 1997 Dec 27; 29(8A):21S-26S. PubMed ID: 9414670
    [No Abstract] [Full Text] [Related]

  • 18. Anti-OKT3 response following prophylactic treatment in paediatric kidney transplant recipients.
    Niaudet P, Jean G, Broyer M, Chatenoud L.
    Pediatr Nephrol; 1993 Jun 27; 7(3):263-7. PubMed ID: 8518095
    [Abstract] [Full Text] [Related]

  • 19. Variations in serum OKT3 concentration based upon age, sex, transplanted organ, treatment regimen, and anti-OKT3 antibody status.
    Schroeder TJ, Michael AT, First MR, Hariharan S, Bhat G, Hanto DW, Ryckman FC, Balistreri WF.
    Ther Drug Monit; 1994 Aug 27; 16(4):361-7. PubMed ID: 7974625
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.